Ipilimumab/nivolumabColitis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1826卷 / 1期

关键词：

D O I：

10.1007/s40278-020-84632-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：185 / 185

相关论文

共 50 条

[21] Ipilimumab/nivolumabColitis, hepatitis and acute renal injury: case report
Reactions Weekly, 2024, 2026 (1) : 161 - 161
[22] Ipilimumab/nivolumabColitis: 2 case reports
Reactions Weekly, 2019, 1735 (1) : 160 - 160
[23] Ipilimumab/nivolumabColitis: 2 case reports
Reactions Weekly, 2020, 1788 (1) : 135 - 135
[24] Ipilimumab/nivolumabColitis: 3 case reports
Reactions Weekly, 2022, 1928 (1) : 213 - 213
[25] Ipilimumab/NivolumabColitis
Reactions Weekly, 2024, 2005 (1) : 464 - 464
[26] Ipilimumab/nivolumabColitis, hyperthyroidism and type 1 diabetes mellitus: case report
Reactions Weekly, 2018, 1705 (1) : 174 - 174
[27] Ipilimumab/nivolumabColitis and diarrhoea: 11 case reports
Reactions Weekly, 2020, 1810 (1) : 120 - 120
[28] Infliximab/ipilimumab/nivolumabColitis and acute drug induced liver injury: case report
Reactions Weekly, 2019, 1754 (1) : 194 - 194
[29] NivolumabColitis: case report
Reactions Weekly, 2021, 1885 (1) : 413 - 413
[30] NivolumabColitis: case report
Reactions Weekly, 2017, 1672 (1) : 201 - 201

← 1 2 3 4 5 →